DGD

DRUG2 trials

Sponsors

MediWound Ltd

Conditions

Burn

Phase 2

Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns

CompletedNCT00898521

MediWound LtdBurn

Start: 2009-12-20End: 2015-12-02Updated: 2021-09-09

Phase 3

Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care

CompletedNCT00324311

MediWound LtdBurn

Start: 2005-12-31End: 2010-02-28Updated: 2011-05-10

Related Papers

A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.

2013-09-26151 citations